glioma

Michael Dewan, MD, MSCI

Study to explore why some gliomas spread like cancerous tumors

Vanderbilt’s Michael Dewan, MD, MSCI, has received a grant from the Pediatric Brain Tumor Foundation to study why some low-grade gliomas, a type of non-cancerous brain or spine tumor, spread and behave like cancerous tumors.

New drugs a good BET for brain cancer

A novel class of drugs that target “BET” proteins may have broad utility for treating genetically diverse brain tumors.

brain illustration

Study links rare genetic marker to brain cancer

Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma.